Press Releases

Sunshine Heart Announces Receipt of Nasdaq Extension to Comply with Listing Requirements

Posted on

EDEN PRAIRIE, Minn., Nov. 22, 2016 (GLOBE NEWSWIRE) — Sunshine Heart, Inc. (NASDAQ:SSH) today announced that on November 21, 2016 it received a letter from the Nasdaq Office of General Counsel indicating that the Panel had granted the Company continued listing on the Nasdaq Capital Market while it implements its plan to regain compliance with […]

Read More

Sunshine Heart Announces Receipt of Additional Nasdaq Staff Determination

Posted on

EDEN PRAIRIE, Minn., Nov. 17, 2016 (GLOBE NEWSWIRE) — Sunshine Heart, Inc. today announced that on November 11, 2016, the Company received a letter from the Nasdaq Listing Qualifications Staff indicating that the Company no longer satisfied the minimum $2.5 million stockholders’ equity requirement for continued listing on The Nasdaq Capital Market based upon the […]

Read More

Sunshine Heart Announces Third Quarter 2016 Financial Results and Provides Company Update

Posted on

EDEN PRAIRIE, Minn., Nov. 08, 2016 (GLOBE NEWSWIRE) — Sunshine Heart, Inc. (NASDAQ:SSH) announced today its financial results for the third quarter ended September 30, 2016. The Company will host a conference call and webcast at 9:00 AM ET today to discuss its financial results and provide an update on the Company’s recently announced strategic […]

Read More

Sunshine Heart Announces Exchange and $3.8 Million Offering

Posted on

EDEN PRAIRIE, Minn., Oct. 31, 2016 (GLOBE NEWSWIRE) — Sunshine Heart, Inc. (Nasdaq:SSH) (“Sunshine Heart” or the “Company”) today announced that it has entered into a definitive agreement with a healthcare dedicated institutional investor for an offering of shares of two series of convertible preferred stock with gross proceeds of $3.8 million in a registered […]

Read More

Sunshine Heart Announces Strategic Realignment

Posted on

EDEN PRAIRIE, Minn., Sept. 29, 2016 (GLOBE NEWSWIRE) — Sunshine Heart, Inc. (NASDAQ:SSH) today announced that it is implementing a strategic realignment of its near term strategy to fully focus the Company’s resources on its recently acquired Aquadex FlexFlow® System.  The Aquadex system is indicated for temporary (up to eight hours) ultrafiltration treatment of patients […]

Read More